Both the apparent loss of LYVE-1 expression and the gain of CD34 expression indicate paracrine interactions between tumour cells and co-opted endothelial cells, yet without eliciting angiogenesis or desmoplasia. This evidence concerns the gene LYVE1 and neoplasm.